{
    "2019-10-25": [
        [
            {
                "time": "2019-10-25",
                "original_text": "【广发策略】消费降温，成长星火—主动偏股型基金19年三季报配置分析",
                "features": {
                    "keywords": [
                        "消费降温",
                        "成长星火",
                        "基金配置"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "成长"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "重磅：13.8万亿公募基金最新重仓股全曝光",
                "features": {
                    "keywords": [
                        "公募基金",
                        "重仓股",
                        "曝光"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "恒瑞进入《财富》50强，研发投入同比增长66.97%，创新药将迎收获期！",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "财富50强",
                        "研发投入",
                        "创新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "北向资金连续2日净流入逾17亿主力资金卖出中国平安",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "中国平安"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "恒瑞医药：三季度业绩超预期，研发费用同比大增60%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "三季度业绩",
                        "研发费用",
                        "超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "港股一周浮浮沉沉最终累计跌52点",
                "features": {
                    "keywords": [
                        "港股",
                        "累计下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "石药集团升幅扩大至逾半成创近一年高位",
                "features": {
                    "keywords": [
                        "石药集团",
                        "升幅",
                        "高位"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "恒瑞医药大涨近6% 创历史新高",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大涨",
                        "历史新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "从仿制药到创新药，恒瑞医药Q3业绩颇丰",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "仿制药",
                        "创新药",
                        "Q3业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-25",
                "original_text": "全球未来50强公司榜单发布，中国一家制药企业入选",
                "features": {
                    "keywords": [
                        "全球50强",
                        "制药企业",
                        "入选"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}